Successful modulation of type 2 diabetes in db/db mice with intra-bone marrow-bone marrow transplantation plus concurrent thymic transplantation

Journal of Autoimmunity

Volumn 35, Issue 4, 2010, Pages 414-423

  Li, Ming ^a   Abraham, Nader G ^b   Vanella, Luca ^b   Zhang, Yuming ^a   Inaba, Muneo ^a   Hosaka, Naoki ^a   Hoshino, Sho Ichi ^a   Shi, Ming ^a   Ambrosini, Yoko Miyamoto ^c   Gershwin, M Eric ^c   Ikehara, Susumu ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b MEDICAL COLLEGE OF OHIO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Db db mice; Intra bone marrow bone marrow transplantation; Thymic transplantation; Type 2 diabetes

Indexed keywords

ACTIN; ADENYLATE KINASE; ADIPONECTIN; CD4 ANTIGEN; CD8 ANTIGEN; CELL PROTEIN; CYTOKINE; GLUCOSE; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN RECEPTOR; PROTEIN HO 1; PROTEIN KINASE B; PROTEIN KINASE LKB1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; BODY WEIGHT; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CD4 CD8 RATIO; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; INSULIN SYNTHESIS; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; THYMUS TRANSPLANTATION; TREATMENT OUTCOME;

ADIPONECTIN; ANIMALS; BLOOD GLUCOSE; BONE MARROW TRANSPLANTATION; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; IMMUNOTHERAPY; INSULIN-SECRETING CELLS; INTERLEUKIN-1BETA; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; RECEPTORS, LEPTIN; T-LYMPHOCYTES; THYMUS GLAND;

EID: 77958124206     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2010.09.001     Document Type: Article

References (58)

1. Despres J.P., Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006, 444:881-887.
2. Nishimura S., Manabe I., Nagasaki M., Eto K., Yamashita H., Ohsugi M., et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 2009, 15:914-920.
3. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
4. Suganami T., Nishida J., Ogawa Y. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler Thromb Vasc Biol 2005, 25:2062-2068.
5. Clift R.A., Thomas E.D. Follow-up 26 years after treatment for acute myelogenous leukemia. N Engl J Med 2004, 351:2456-2457.
6. Ikehara S., Ohtsuki H., Good R.A., Asamoto H., Nakamura T., Sekita K., et al. Prevention of type I diabetes in nonobese diabetic mice by allogenic bone marrow transplantation. Proc Natl Acad Sci U S A 1985, 82:7743-7747.
7. Ikehara S., Good R.A., Nakamura T., Sekita K., Inoue S., Oo M.M., et al. Rationale for bone marrow transplantation in the treatment of autoimmune diseases. Proc Natl Acad Sci U S A 1985, 82:2483-2487.
8. Than S., Ishida H., Inaba M., Fukuba Y., Seino Y., Adachi M., et al. Bone marrow transplantation as a strategy for treatment of non-insulin-dependent diabetes mellitus in KK-Ay mice. J Exp Med 1992, 176:1233-1238.
9. Gershwin M.E. Bone marrow transplantation, refractory autoimmunity and the contributions of Susumu Ikehara. J Autoimmun 2008, 30:105-107.
10. Ikehara S. A novel method of bone marrow transplantation (BMT) for intractable autoimmune diseases. J Autoimmun 2008, 30:108-115.
11. Burt R.K., Testori A., Craig R., Cohen B., Suffit R., Barr W. Hematopoietic stem cell transplantation for autoimmune diseases: what have we learned?. J Autoimmun 2008, 30:116-120.
12. Ozawa K., Sato K., Oh I., Ozaki K., Uchibori R., Obara Y., et al. Cell and gene therapy using mesenchymal stem cells (MSCs). J Autoimmun 2008, 30:121-127.
13. Abraham N.G., Li M., Vanella L., Peterson S.J., Ikehara S., Asprinio D. Bone marrow stem cell transplant into intra-bone cavity prevents type 2 diabetes: role of heme oxygenase-adiponectin. J Autoimmun 2008, 30:128-135.
14. Sonoda Y. Immunophenotype and functional characteristics of human primitive CD34-negative hematopoietic stem cells: the significance of the intra-bone marrow injection. J Autoimmun 2008, 30:136-144.
15. Marmont A.M. Will hematopoietic stem cell transplantation cure human autoimmune diseases?. J Autoimmun 2008, 30:145-150.
16. Ratajczak M.Z., Zuba-Surma E.K., Wysoczynski M., Wan W., Ratajczak J., Wojakowski W., et al. Hunt for pluripotent stem cell - regenerative medicine search for almighty cell. J Autoimmun 2008, 30:151-162.
17. Hara M., Murakami T., Kobayashi E. In vivo bioimaging using photogenic rats: fate of injected bone marrow-derived mesenchymal stromal cells. J Autoimmun 2008, 30:163-171.
18. Rezvani A.R., Storb R.F. Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantation. J Autoimmun 2008, 30:172-179.
19. Deane S., Meyers F.J., Gershwin M.E. On reversing the persistence of memory: hematopoietic stem cell transplant for autoimmune disease in the first ten years. J Autoimmun 2008, 30:180-196.
20. Hosaka N., Nose M., Kyogoku M., Nagata N., Miyashima S., Good R.A., et al. Thymus transplantation, a critical factor for correction of autoimmune disease in aging MRL/+mice. Proc Natl Acad Sci U S A 1996, 93:8558-8562.
21. Ryu T., Hosaka N., Miyake T., Cui W., Nishida T., Takaki T., et al. Transplantation of newborn thymus plus hematopoietic stem cells can rescue supralethally irradiated mice. Bone Marrow Transplant 2008, 41:659-666.
22. Hosaka N., Ryu T., Miyake T., Cui W., Nishida T., Takaki T., et al. Treatment of autoimmune diseases in MRL/lpr mice by allogenic bone marrow transplantation plus adult thymus transplantation. Clin Exp Immunol 2007, 147:555-563.
23. Kushida T., Inaba M., Hisha H., Ichioka N., Esumi T., Ogawa R., et al. Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice. Blood 2001, 97:3292-3299.
24. Peterson S.J., Kim D.H., Li M., Positano V., Vanella L., Rodella L.F., et al. The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice. J Lipid Res 2009, 50:1293-1304.
25. Li M., Kim D.H., Tsenovoy P.L., Peterson S.J., Rezzani R., Rodella L.F., et al. Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance. Diabetes 2008, 57:1526-1535.
26. Lord G.M., Matarese G., Howard J.K., Baker R.J., Bloom S.R., Lechler R.I. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998, 394:897-901.
27. Martin-Romero C., Santos-Alvarez J., Goberna R., Sanchez-Margalet V. Human leptin enhances activation and proliferation of human circulating T lymphocytes. Cell Immunol 2000, 199:15-24.
28. Lord G.M., Matarese G., Howard J.K., Bloom S.R., Lechler R.I. Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokines. J Leukoc Biol 2002, 72:330-338.
29. Fujita Y., Murakami M., Ogawa Y., Masuzaki H., Tanaka M., Ozaki S., et al. Leptin inhibits stress-induced apoptosis of T lymphocytes. Clin Exp Immunol 2002, 128:21-26.
30. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994, 372:425-432.
31. Chua S.C., Chung W.K., Wu-Peng X.S., Zhang Y., Liu S.M., Tartaglia L., et al. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 1996, 271:994-996.
32. Fantuzzi G., Faggioni R. Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol 2000, 68:437-446.
33. Matarese G., Moschos S., Mantzoros C.S. Leptin in immunology. J Immunol 2005, 174:3137-3142.
34. Fernandes G., Handwerger B.S., Yunis E.J., Brown D.M. Immune response in the mutant diabetic C57BL/Ks-dt+ mouse. Discrepancies between in vitro and in vivo immunological assays. J Clin Invest 1978, 61:243-250.
35. Kimura M., Tanaka S., Isoda F., Sekigawa K., Yamakawa T., Sekihara H. T lymphopenia in obese diabetic (db/db) mice is non-selective and thymus independent. Life Sci 1998, 62:1243-1250.
36. Gainsford T., Willson T.A., Metcalf D., Handman E., McFarlane C., Ng A., et al. Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. Proc Natl Acad Sci U S A 1996, 93:14564-14568.
37. Thomas T., Gori F., Khosla S., Jensen M.D., Burguera B., Riggs B.L. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. Endocrinology 1999, 140:1630-1638.
38. Hathout E.H., Thomas W., El-Shahawy M., Nahab F., Mace J.W. Diabetic autoimmune markers in children and adolescents with type 2 diabetes. Pediatrics 2001, 107:E102.
39. Umpaichitra V., Banerji M.A., Castells S. Autoantibodies in children with type 2 diabetes mellitus. J Pediatr Endocrinol Metab 2002, 15(Suppl. 1):525-530.
40. Gilliam L.K., Brooks-Worrell B.M., Palmer J.P., Greenbaum C.J., Pihoker C. Autoimmunity and clinical course in children with type 1, type 2, and type 1.5 diabetes. J Autoimmun 2005, 25:244-250.
41. Songer T., Glazner J., Coombs L.P., Cuttler L., Daniel M., Estrada S., et al. Examining the economic costs related to lifestyle and pharmacological interventions in youth with type 2 diabetes. Expert Rev Pharmacoecon Outcomes Res 2006, 6:315-324.
42. Reinehr T., Schober E., Wiegand S., Thon A., Holl R. Beta-cell autoantibodies in children with type 2 diabetes mellitus: subgroup or misclassification?. Arch Dis Child 2006, 91:473-477.
43. Klingensmith G.J., Pyle L., Arslanian S., Copeland K.C., Cuttler L., Kaufman F., et al. The presence of GAD and IA-2 antibodies in youth with a type 2 diabetes phenotype: results from the TODAY study. Diabetes Care 2010.
44. Flaquer M., Franquesa M., Barquinero J., Lloberas N., Gutierrez C., Torras J., et al. Bone marrow transplantation induces normoglycemia in a type 2 diabetes mellitus murine model. Transplant Proc 2009, 41:2282-2285.
45. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005, 115:911-919. quiz 20.
46. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes 1991, 40:405-412.
47. Li M., Peterson S., Husney D., Inaba M., Guo K., Terada E., et al. Interdiction of the diabetic state in NOD mice by sustained induction of heme oxygenase: possible role of carbon monoxide and bilirubin. Antioxid Redox Signal 2007, 9:855-863.
48. Li M., Peterson S., Husney D., Inaba M., Guo K., Kappas A., et al. Long-lasting expression of HO-1 delays progression of type I diabetes in NOD mice. Cell Cycle 2007, 6:567-571.
49. Weir G.C., Marselli L., Marchetti P., Katsuta H., Jung M.H., Bonner-Weir S. Towards better understanding of the contributions of overwork and glucotoxicity to the beta-cell inadequacy of type 2 diabetes. Diabetes Obes Metab 2009, 11(Suppl. 4):82-90.
50. Kosaka K., Kuzuya T., Akanuma Y., Hagura R. Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment. Diabetologia 1980, 18:23-28.
51. MacDonald M.J., Efendic S., Ostenson C.G. Normalization by insulin treatment of low mitochondrial glycerol phosphate dehydrogenase and pyruvate carboxylase in pancreatic islets of the GK rat. Diabetes 1996, 45:886-890.
52. Boumaza I., Srinivasan S., Witt W.T., Feghali-Bostwick C., Dai Y., Garcia-Ocana A., et al. Autologous bone marrow-derived rat mesenchymal stem cells promote PDX-1 and insulin expression in the islets, alter T cell cytokine pattern and preserve regulatory T cells in the periphery and induce sustained normoglycemia. J Autoimmun 2009, 32:33-42.
53. Theise N.D., Nimmakayalu M., Gardner R., Illei P.B., Morgan G., Teperman L., et al. Liver from bone marrow in humans. Hepatology 2000, 32:11-16.
54. Oswald J., Boxberger S., Jorgensen B., Feldmann S., Ehninger G., Bornhauser M., et al. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 2004, 22:377-384.
55. Li M., Inaba M., Guo K.Q., Hisha H., Abraham N.G., Ikehara S. Treatment of streptozotocin-induced diabetes mellitus in mice by intra-bone marrow bone marrow transplantation plus portal vein injection of beta cells induced from bone marrow cells. Int J Hematol 2007, 86:438-445.
56. Hamrick M.W., Della-Fera M.A., Choi Y.H., Pennington C., Hartzell D., Baile C.A. Leptin treatment induces loss of bone marrow adipocytes and increases bone formation in leptin-deficient ob/ob mice. J Bone Miner Res 2005, 20:994-1001.
57. Chow F.Y., Nikolic-Paterson D.J., Atkins R.C., Tesch G.H. Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis. Nephrol Dial Transplant 2004, 19:2987-2996.
58. Chow F., Ozols E., Nikolic-Paterson D.J., Atkins R.C., Tesch G.H. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int 2004, 65:116-128.